Timothy M. Shannon, M.D.

Former President and CEO, CuraGen Corporation

Dr. Shannon became a Director of Celldex in October 2009 upon the acquisition of CuraGen by Celldex. Dr. Shannon served as CuraGen's President and Chief Executive Officer from September 2007 to October 2009, Executive Vice President and Chief Medical Officer from January 2004 to September 2007, and Senior Vice President of Research and Development from September 2002 to December 2003. He previously worked in positions of increasing responsibility for Bayer's Pharmaceutical Business Group, where his last position was Head and Senior Vice President of Global Medical Development. Dr. Shannon earned his B.A. in Chemistry from Amherst College and his M.D. from the University of Connecticut School of Medicine.